Joyoti Basu
- January 10, 2024
- Academic
Quick Facts
Full Name | Joyoti Basu |
Occupation | Academic |
Date Of Birth | Dec 17, 1957(1957-12-17) |
Age | 67 |
Birthplace | West Bengal |
Country | India |
Horoscope | Aquarius |
Joyoti Basu Biography
Name | Joyoti Basu |
Birthday | Dec 17 |
Birth Year | 1957 |
Place Of Birth | West Bengal |
Birth Country | India |
Birth Sign | Aquarius |
Joyoti Basu is one of the most popular and richest Academic who was born on December 17, 1957 in West Bengal, India. Born on 17 December 1957 in the Indian state of West Bengal, Joyoti Basu did her undergraduate studies at the Presidency College, Kolkata and after completing the BSc honors in chemistry, she obtained an MSc from the University of Calcutta. Her doctoral research was at the Bose Institute, Kolkata under the guidance of Parul Chakrabarti, which earned her a PhD from Calcutta University. She did her post-doctoral work at the laboratory of Jean-Marie Ghuysen at the University of Liege working on mycobacterial cell division and mycobacterial peptidoglycan-biosynthesizing enzymes. She joined Bose Institute in 1991 as a faculty member at the department of Chemistry and retired in June, 2018. Basu resides along Madhab Chatterjee Street in Kolkata.
Basu’s research is focused on the cellular and molecular biology of mycobacteria. During the initial stages of her career, she worked on the membrane structure of red blood cells and her research is reported to have assisted in widening the understanding of apoptosis of nucleated mammalian cells and the physiology of the red cell that lacked a cell nucleus. Her association with her mentor, Parul Chakrabarti, during her doctoral research days, precipitated the studies of the biosynthetic pathways of fatty acids in relation to cell wall building and the functions of penicillin-binding proteins. She is known to be the first scientist to propose that the removal of the aged or oxidatively stressed red blood cells from the circulatory system causes cellular death. Later she moved on to the biological study of Mycobacterium tuberculosis, a pathogenic bacteria causing tuberculosis, with regard to its host-pathogen interaction and her studies revealed the mechanisms of macrophage apoptosis as well as the relationship between host cell signaling and innate immune response. In 2007, the team led by Basu and her college mate from the Presidency College, Manikuntala Kundu, were successful in identifying a protein in Mycobacterium tuberculosis which caused weakening of the immune system of the host. They found that the protein, named Early Secreted Antigen 6, which bound themselves on Toll-like receptor 2 of the host, hindered the production of cytokines, a type of protein which helped the immune system to fight the tuberculosis bacteria. The discovery also has reported importance in the therapeutics of diseases like rheumatoid arthritis. The achievement was later published as an article, Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages in Nature Immunology journal in 2007. Her studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 77 of them. Besides, she has mentored several research scholars in their doctoral studies.
Joyoti Basu Net Worth
Net Worth | $5 Million |
Source Of Income | Academic |
House | Living in own house. |
Joyoti Basu is one of the richest Academic from India. According to our analysis, Wikipedia, Forbes & Business Insider, Joyoti Basu 's net worth $5 Million. (Last Update: December 11, 2023)
Joyoti Basu (born 17 December 1957) is an Indian biochemist, cell biologist and a senior professor at the Bose Institute. Known for her studies on the membrane structure of red blood cells, Basu is an elected fellow of the all the three major Indian science academies namely National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy as well as the Indian Society for Chemical Biology. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2002.
Basu received the Young Scientist Medal of the Indian National Science Academy in 1989. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards in 2002. The National Academy of Sciences, India elected her as a fellow the same year. She received the elected fellowships of the Indian Academy of Sciences and the Indian National Academy of Sciences in 2006 and 2009 respectively. She is a recipient of the J.C. Bose National Fellowship in 2017.
Height, Weight & Body Measurements
Joyoti Basu height Not available right now. Takeyuki weight Not Known & body measurements will update soon.
Who is Joyoti Basu Dating?
According to our records, Joyoti Basu is possibily single & has not been previously engaged. As of December 1, 2023, Joyoti Basu’s is not dating anyone.
Relationships Record : We have no records of past relationships for Joyoti Basu. You may help us to build the dating records for Joyoti Basu!
Facts & Trivia
Takeyuki Ranked on the list of most popular Academic. Also ranked in the elit list of famous people born in India. Joyoti Basu celebrates birthday on December 17 of every year.
Top Facts about Joyoti Basu
- Joyoti Basu is an Indian medical researcher.
- She specializes in cancer research and immunology.
- Basu has published over 60 research papers.
- She received her PhD from the University of Calcutta.
- Basu completed postdoctoral training at Harvard Medical School.
- Her work focuses on understanding immune responses to cancer cells.
- Basu has received numerous awards for her research contributions.
- She is a faculty member at the Indian Institute of Science Education and Research Kolkata.
- Basu’s research has potential implications for cancer treatment development.
- She is considered a rising star in the field of cancer immunology.